1. ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib. (December 2019) Authors: Thunnissen, E.; Lissenberg-Witte, B.I.; van den Heuvel, M.M.; Monkhorst, K.; Skov, B.G.; Sørensen, J.B.; Mellemgaard, A.; Dingemans, A.M.C.; Speel, E.J.M.; de Langen, A.J.; Hashemi, S.M.S.; Bahce, I.; van der Drift, M.A.; Looijen-Salamon, M.G.; Gosney, J.; Postmus, P.E.; Samii, S.M.S.; Duplaquet,... Journal: Lung cancer Issue: Volume 138(2019) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗